Saturday, 05 December 2020

Simcere appoints Dr. Zang Jingwu as CSO

17 October 2013 | Influencers | By BioSpectrum Bureau

Singapore: China based Simcere Pharmaceutical has appointed Dr. Zang Jingwu as Chief Scientific Officer, effective October 8, 2013.

Dr. Zang received his medical degree from Shanghai JiaoTong University School of Medicine. He earned a PhD from the University of Brussels and was a post-doctoral fellow at Harvard Medical School. Dr. Zang later joined the faculty of Baylor College of Medicine as a professor of Neurology and holds a medical license in the State of Texas in US.

Mr. Hongquan Liu, Chief Executive Officer, Simcere, said, "We are extremely pleased that Jingwu will be joining the Simcere management team to lead our R&D efforts. With his rich industry experience and solid knowledge of new drug development, we are confident that Jingwu will be an important contributor to Simcere as we continue to broaden our pipeline of innovative medicines."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account